ARCHIVES

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Supporters And A Critic Of Burzynski Comment

October 30, 1998

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

August 14, 1992

False-Positive Mammograms Can Indicate Higher Cancer Risk

April 27, 2012

VEGF Levels Can Predict Tumor’s Resistance to Avastin

July 29, 2011

ACCC Presses Drive for “DG 471” But Former President Says it’s Counterproductive

March 30, 1984

In Brief: MB Ends Apportionment Carlo Croce To Head Fels Institute, Replacing Peter Magee Sept. 1

March 4, 1988